カテゴリー： QYResearch, 世界

世界の炎症性腸疾患治療市場 2019年

【英語タイトル】Global Inflammatory Bowel Disease Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X09776）・商品コード：DATA909X09776
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、炎症性腸疾患治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤に、用途別には、小売薬局、病院薬局、オンライン薬局にセグメント区分し、炎症性腸疾患治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・炎症性腸疾患治療の世界市場概要
・炎症性腸疾患治療の製造コスト構成分析
・炎症性腸疾患治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・炎症性腸疾患治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・炎症性腸疾患治療のセグメント分析（種類別）
（アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤）
・炎症性腸疾患治療のセグメント分析（用途別）
（小売薬局、病院薬局、オンライン薬局）
・炎症性腸疾患治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AbbVie, Inc.、Pfizer, Inc.、Allergan plc.、Shire Plc、Novartis AG、Janssen Biotech, Inc. (Johnson & Johnson)、UCB Inc.、Biogen Inc.、Takeda Pharmaceutical Company Limited.、Valeant Pharmaceuticals International, Inc.、）
・炎症性腸疾患治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inflammatory Bowel Disease Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Inflammatory Bowel Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Inflammatory Bowel Disease Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie, Inc.
Pfizer, Inc.
Allergan plc.
Shire Plc
Novartis AG
Janssen Biotech, Inc. (Johnson & Johnson)
UCB Inc.
Biogen Inc.
Takeda Pharmaceutical Company Limited.
Valeant Pharmaceuticals International, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Aminosalicyclates
TNF Inhibitors
Corticosteroids
Immunomodulators

Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Inflammatory Bowel Disease Treatment
1.1 Definition of Inflammatory Bowel Disease Treatment
1.2 Inflammatory Bowel Disease Treatment Segment by Type
1.2.1 Global Inflammatory Bowel Disease Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Aminosalicyclates
1.2.3 TNF Inhibitors
1.2.4 Corticosteroids
1.2.5 Immunomodulators
1.3 Inflammatory Bowel Disease Treatment Segment by Applications
1.3.1 Global Inflammatory Bowel Disease Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Inflammatory Bowel Disease Treatment Overall Market
1.4.1 Global Inflammatory Bowel Disease Treatment Revenue (2014-2025)
1.4.2 Global Inflammatory Bowel Disease Treatment Production (2014-2025)
1.4.3 North America Inflammatory Bowel Disease Treatment Status and Prospect (2014-2025)
1.4.4 Europe Inflammatory Bowel Disease Treatment Status and Prospect (2014-2025)
1.4.5 China Inflammatory Bowel Disease Treatment Status and Prospect (2014-2025)
1.4.6 Japan Inflammatory Bowel Disease Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Inflammatory Bowel Disease Treatment Status and Prospect (2014-2025)
1.4.8 India Inflammatory Bowel Disease Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Treatment
2.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Treatment
2.4 Industry Chain Structure of Inflammatory Bowel Disease Treatment

3 Development and Manufacturing Plants Analysis of Inflammatory Bowel Disease Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Inflammatory Bowel Disease Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Inflammatory Bowel Disease Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Inflammatory Bowel Disease Treatment Production and Capacity Analysis
4.2 Inflammatory Bowel Disease Treatment Revenue Analysis
4.3 Inflammatory Bowel Disease Treatment Price Analysis
4.4 Market Concentration Degree

5 Inflammatory Bowel Disease Treatment Regional Market Analysis
5.1 Inflammatory Bowel Disease Treatment Production by Regions
5.1.1 Global Inflammatory Bowel Disease Treatment Production by Regions
5.1.2 Global Inflammatory Bowel Disease Treatment Revenue by Regions
5.2 Inflammatory Bowel Disease Treatment Consumption by Regions
5.3 North America Inflammatory Bowel Disease Treatment Market Analysis
5.3.1 North America Inflammatory Bowel Disease Treatment Production
5.3.2 North America Inflammatory Bowel Disease Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Inflammatory Bowel Disease Treatment Import and Export
5.4 Europe Inflammatory Bowel Disease Treatment Market Analysis
5.4.1 Europe Inflammatory Bowel Disease Treatment Production
5.4.2 Europe Inflammatory Bowel Disease Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Inflammatory Bowel Disease Treatment Import and Export
5.5 China Inflammatory Bowel Disease Treatment Market Analysis
5.5.1 China Inflammatory Bowel Disease Treatment Production
5.5.2 China Inflammatory Bowel Disease Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Inflammatory Bowel Disease Treatment Import and Export
5.6 Japan Inflammatory Bowel Disease Treatment Market Analysis
5.6.1 Japan Inflammatory Bowel Disease Treatment Production
5.6.2 Japan Inflammatory Bowel Disease Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Inflammatory Bowel Disease Treatment Import and Export
5.7 Southeast Asia Inflammatory Bowel Disease Treatment Market Analysis
5.7.1 Southeast Asia Inflammatory Bowel Disease Treatment Production
5.7.2 Southeast Asia Inflammatory Bowel Disease Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Inflammatory Bowel Disease Treatment Import and Export
5.8 India Inflammatory Bowel Disease Treatment Market Analysis
5.8.1 India Inflammatory Bowel Disease Treatment Production
5.8.2 India Inflammatory Bowel Disease Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Inflammatory Bowel Disease Treatment Import and Export

6 Inflammatory Bowel Disease Treatment Segment Market Analysis (by Type)
6.1 Global Inflammatory Bowel Disease Treatment Production by Type
6.2 Global Inflammatory Bowel Disease Treatment Revenue by Type
6.3 Inflammatory Bowel Disease Treatment Price by Type

7 Inflammatory Bowel Disease Treatment Segment Market Analysis (by Application)
7.1 Global Inflammatory Bowel Disease Treatment Consumption by Application
7.2 Global Inflammatory Bowel Disease Treatment Consumption Market Share by Application (2014-2019)

8 Inflammatory Bowel Disease Treatment Major Manufacturers Analysis
8.1 AbbVie, Inc.
8.1.1 AbbVie, Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.1.2 AbbVie, Inc. Product Introduction, Application and Specification
8.1.3 AbbVie, Inc. Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer, Inc.
8.2.1 Pfizer, Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.2.2 Pfizer, Inc. Product Introduction, Application and Specification
8.2.3 Pfizer, Inc. Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Allergan plc.
8.3.1 Allergan plc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.3.2 Allergan plc. Product Introduction, Application and Specification
8.3.3 Allergan plc. Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Shire Plc
8.4.1 Shire Plc Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.4.2 Shire Plc Product Introduction, Application and Specification
8.4.3 Shire Plc Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Novartis AG
8.5.1 Novartis AG Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.5.2 Novartis AG Product Introduction, Application and Specification
8.5.3 Novartis AG Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Janssen Biotech, Inc. (Johnson & Johnson)
8.6.1 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.6.2 Janssen Biotech, Inc. (Johnson & Johnson) Product Introduction, Application and Specification
8.6.3 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 UCB Inc.
8.7.1 UCB Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.7.2 UCB Inc. Product Introduction, Application and Specification
8.7.3 UCB Inc. Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biogen Inc.
8.8.1 Biogen Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.8.2 Biogen Inc. Product Introduction, Application and Specification
8.8.3 Biogen Inc. Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Takeda Pharmaceutical Company Limited.
8.9.1 Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.9.2 Takeda Pharmaceutical Company Limited. Product Introduction, Application and Specification
8.9.3 Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Valeant Pharmaceuticals International, Inc.
8.10.1 Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
8.10.2 Valeant Pharmaceuticals International, Inc. Product Introduction, Application and Specification
8.10.3 Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Inflammatory Bowel Disease Treatment Market
9.1 Global Inflammatory Bowel Disease Treatment Market Trend Analysis
9.1.1 Global Inflammatory Bowel Disease Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Inflammatory Bowel Disease Treatment Regional Market Trend
9.2.1 North America Inflammatory Bowel Disease Treatment Forecast 2019-2025
9.2.2 Europe Inflammatory Bowel Disease Treatment Forecast 2019-2025
9.2.3 China Inflammatory Bowel Disease Treatment Forecast 2019-2025
9.2.4 Japan Inflammatory Bowel Disease Treatment Forecast 2019-2025
9.2.5 Southeast Asia Inflammatory Bowel Disease Treatment Forecast 2019-2025
9.2.6 India Inflammatory Bowel Disease Treatment Forecast 2019-2025
9.3 Inflammatory Bowel Disease Treatment Market Trend (Product Type)
9.4 Inflammatory Bowel Disease Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Inflammatory Bowel Disease Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Inflammatory Bowel Disease Treatment
Table Global Inflammatory Bowel Disease Treatment Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Inflammatory Bowel Disease Treatment Production Market Share by Types in 2018
Figure Aminosalicyclates Product Picture
Figure TNF Inhibitors Product Picture
Figure Corticosteroids Product Picture
Figure Immunomodulators Product Picture
Table Global Inflammatory Bowel Disease Treatment Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Inflammatory Bowel Disease Treatment Consumption Market Share by Applications in 2018
Figure Retail Pharmacies
Figure Hospital Pharmacies
Figure Online Pharmacies
Figure Global Inflammatory Bowel Disease Treatment Revenue (Million USD) (2014-2025)
Figure Global Inflammatory Bowel Disease Treatment Production (K Units) (2014-2025)
Figure North America Inflammatory Bowel Disease Treatment Market Size (Million USD) (2014-2025)
Figure Europe Inflammatory Bowel Disease Treatment Market Size (Million USD) (2014-2025)
Figure China Inflammatory Bowel Disease Treatment Market Size (Million USD) (2014-2025)
Figure Japan Inflammatory Bowel Disease Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Inflammatory Bowel Disease Treatment Market Size (Million USD) (2014-2025)
Figure India Inflammatory Bowel Disease Treatment Market Size (Million USD) (2014-2025)
Table Inflammatory Bowel Disease Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Treatment in 2018
Figure Manufacturing Process Analysis of Inflammatory Bowel Disease Treatment
Figure Industry Chain Structure of Inflammatory Bowel Disease Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Inflammatory Bowel Disease Treatment Manufacturing Plants Distribution
Table Inflammatory Bowel Disease Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Inflammatory Bowel Disease Treatment Capacity (K Units) of Major Manufacturers (2014-2019)
Table Inflammatory Bowel Disease Treatment Production (K Units) of Major Manufacturers (2014-2019)
Table Inflammatory Bowel Disease Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Inflammatory Bowel Disease Treatment Production Share by Manufacturers in 2018
Table Inflammatory Bowel Disease Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Inflammatory Bowel Disease Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Inflammatory Bowel Disease Treatment Revenue Share by Manufacturers in 2018
Table Inflammatory Bowel Disease Treatment Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Inflammatory Bowel Disease Treatment Production by Regions 2014-2019 (K Units)
Table Global Inflammatory Bowel Disease Treatment Production Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Treatment Production Market Share by Regions in 2018
Table Global Inflammatory Bowel Disease Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Inflammatory Bowel Disease Treatment Revenue Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Treatment Revenue Market Share by Regions in 2018
Table Global Inflammatory Bowel Disease Treatment Consumption by Regions 2014-2019 (K Units)
Table Global Inflammatory Bowel Disease Treatment Consumption Market Share by Regions 2014-2019
Figure North America Inflammatory Bowel Disease Treatment Production Growth Rate 2014-2019 (K Units)
Figure North America Inflammatory Bowel Disease Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Inflammatory Bowel Disease Treatment Production, Consumption Import and Export (K Units)
Figure Europe Inflammatory Bowel Disease Treatment Production Growth Rate 2014-2019 (K Units)
Figure Europe Inflammatory Bowel Disease Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Inflammatory Bowel Disease Treatment Production, Consumption Import and Export (K Units)
Figure China Inflammatory Bowel Disease Treatment Production Growth Rate 2014-2019 (K Units)
Figure China Inflammatory Bowel Disease Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Inflammatory Bowel Disease Treatment Production, Consumption Import and Export (K Units)
Figure Japan Inflammatory Bowel Disease Treatment Production Growth Rate 2014-2019 (K Units)
Figure Japan Inflammatory Bowel Disease Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Inflammatory Bowel Disease Treatment Production, Consumption Import and Export (K Units)
Figure Southeast Asia Inflammatory Bowel Disease Treatment Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Inflammatory Bowel Disease Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Inflammatory Bowel Disease Treatment Production, Consumption Import and Export (K Units)
Figure India Inflammatory Bowel Disease Treatment Production Growth Rate 2014-2019 (K Units)
Figure India Inflammatory Bowel Disease Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Inflammatory Bowel Disease Treatment Production, Consumption Import and Export (K Units)
Figure Global Consumption Inflammatory Bowel Disease Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Inflammatory Bowel Disease Treatment Market Share by Application (2014-2019)
Table AbbVie, Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table AbbVie, Inc. Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table AbbVie, Inc. Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie, Inc. Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table AbbVie, Inc. Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure AbbVie, Inc. Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table AbbVie, Inc. Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Pfizer, Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Pfizer, Inc. Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Pfizer, Inc. Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer, Inc. Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Pfizer, Inc. Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Pfizer, Inc. Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Pfizer, Inc. Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Allergan plc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Allergan plc. Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Allergan plc. Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan plc. Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Allergan plc. Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Allergan plc. Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Allergan plc. Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Shire Plc Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Shire Plc Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Shire Plc Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Plc Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Shire Plc Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Shire Plc Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Shire Plc Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Novartis AG Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Novartis AG Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Novartis AG Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Novartis AG Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Novartis AG Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Novartis AG Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table UCB Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table UCB Inc. Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table UCB Inc. Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table UCB Inc. Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table UCB Inc. Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure UCB Inc. Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table UCB Inc. Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Biogen Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Biogen Inc. Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Biogen Inc. Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Inc. Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Biogen Inc. Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Biogen Inc. Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Biogen Inc. Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Takeda Pharmaceutical Company Limited. Inflammatory Bowel Disease Treatment Main Business and Markets Served
Table Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Production Sites and Area Served
Table Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Product Introduction, Application and Specification
Table Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Production Growth Rate (2014-2019)
Table Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Production Market Share (2014-2019)
Figure Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Revenue Market Share (2014-2019)
Table Valeant Pharmaceuticals International, Inc. Inflammatory Bowel Disease Treatment Main Business and Markets Served
Figure Global Inflammatory Bowel Disease Treatment Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Inflammatory Bowel Disease Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Inflammatory Bowel Disease Treatment Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Inflammatory Bowel Disease Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Inflammatory Bowel Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Inflammatory Bowel Disease Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Inflammatory Bowel Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Inflammatory Bowel Disease Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Inflammatory Bowel Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Inflammatory Bowel Disease Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Inflammatory Bowel Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Inflammatory Bowel Disease Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Inflammatory Bowel Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Inflammatory Bowel Disease Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Inflammatory Bowel Disease Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Inflammatory Bowel Disease Treatment by Type (2019-2025)
Table Global Consumption (K Units) of Inflammatory Bowel Disease Treatment by Application (2019-2025)
Table Inflammatory Bowel Disease Treatment Distributors List
Table Inflammatory Bowel Disease Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AbbVie, Inc.、Pfizer, Inc.、Allergan plc.、Shire Plc、Novartis AG、Janssen Biotech, Inc. (Johnson & Johnson)、UCB Inc.、Biogen Inc.、Takeda Pharmaceutical Company Limited.、Valeant Pharmaceuticals International, Inc.、

★調査レポート[世界の炎症性腸疾患治療市場 2019年] (コード：DATA909X09776)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の炎症性腸疾患治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 炎症性腸疾患療法の世界市場：規模・現状・予測2019-2025
    DATA909X18567 / QYResearch / 2019年11月25日 / ※当調査レポートでは、炎症性腸疾患療法の世界市場について調査・分析し、炎症性腸疾患療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（潰瘍性大腸炎、クローン病、その他）、用途別（病院、医学研究機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の炎症性腸疾患療法市場動向 ・主要企業別マーケットシェア ・炎症性腸疾患療法の種類別市場規模2014-2019 （潰瘍性大腸炎、クローン病、その他） ・炎症性腸疾患療法の用途別市場規模2014-2019 （病院、医学研究機関、その他） ・炎症性腸疾患療法の北米市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.In 2018, the global Inflammatory Bowel Disease Therapy market size was...
  • 世界のレイノーズ病治療市場 2019年
    DATA909X14126 / QYResearch / 2019年11月20日 / ※本調査レポートは、レイノーズ病治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アセチルシステイン、アルプロスタジル、ELS-140、血管新生物質、ニトログリセリン、その他に、用途別には、病院、診療所、その他にセグメント区分し、レイノーズ病治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・レイノーズ病治療の世界市場概要 ・レイノーズ病治療の製造コスト構成分析 ・レイノーズ病治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・レイノーズ病治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・レイノーズ病治療のセグメント分析（種類別） （アセチルシステイン、アルプロスタジル、ELS-140、血管新生物質、ニトログリセリン、その他）...The global Raynauds Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Raynauds Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Raynauds Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Raynauds Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のウィルソン病治療市場 2019年
    DATA909X17798 / QYResearch / 2019年11月22日 / ※本調査レポートは、ウィルソン病治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、D-ペニシラミン、トリエンチン、テトラチオモリブデート、その他に、用途別には、病院、クリニック、その他にセグメント区分し、ウィルソン病治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ウィルソン病治療の世界市場概要 ・ウィルソン病治療の製造コスト構成分析 ・ウィルソン病治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ウィルソン病治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ウィルソン病治療のセグメント分析（種類別） （D-ペニシラミン、トリエンチン、テトラチオモリブデート、その他）...The global Wilson's Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Wilson's Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Wilson's Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Wilson's Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆